At Novo Nordisk, we are driving change to defeat diabetes and other serious chronic conditions.
Novo Nordisk Canada Inc. is an affiliate of Novo Nordisk A/S, a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: hemophilia, growth disorders and obesity.
Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 80 countries and markets its products in 170 countries.
member
With about 70 patents, series of fundings, and an innovative product line, primarily to address the prevention and removal of microbial biofilms, finally the 19-year-old company makes it big in the bioscience industry!
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.